Last October Aschwin de Wolf replied to misinterpretations of his presentation at the 2011 CI AGM with the following statement which he authorized me to reproduce at that time, and which I will reproduce again here. -- Ben Best
** Aschwin's comments below *
It has come to our attention that our recent presentation has caused some controversy on the CI members mailing list. As far as we can tell, a lot of the criticism is aimed at how other people (including Alcor Officials) have interpreted our presentation. In our presentation there is no comparison between Alcor and CI at all. As a matter of fact, we deliberately avoided framing the issue like this. Our presentation just summarized the practical implications of our research for cryonics. One of the most robust findings in our studies, and scientific papers of others researchers going back to the 1960s, is that cerebral ischemia produces perfusion impairment in the brain in a time- and temperature dependent manner. In cryonics such perfusion impairment translates itself into ice formation. The real difference is not between Alcor and CI but between people who do not receive rapid stabilization and cooling and those who do. In ourpresentation we outlined a number of things CI members can do to reduce warm and cold ischemia, including relocation and ensuring that there will be rapid cooling after pronouncement of legal death. We did not use the phrase "2/3 of CI members" in our slides but we did point out that the majority of CI members experience prolonged periods of warm and cold ischemia - this can be easily verified by checking the case reports on the CI website. Such ischemic delays produce perfusion impairment and ice formation. Most CI members can do something about the probability of this happening to them, so this can hardly be construed as an endorsement of Alcor. As a matter of fact, speaking for myself, I prefer a model where a cryonics organization leaves more flexibility to its members as to whether and how to make arrangements to prevent injury to the brain after pronouncement of legal death. We would never claim that the ischemia that many CI members experience is catastrophic because we do not know what future cell repair technologies will be capable of. Of course, this should not excuse people to limit postmortem damage as much as they can.
Having said all this, this does not mean that research cannot contribute to mitigating some of the effects of prolonged warm and cold ischemia. We made a number of recommendations during our presentation and hope to present a more comprehensive set of technical recommendations to improve CI procedures in the near future. We had constructive exchanges about this with Ben and Andy.
I searched but did not find any discussion comparing the merits of the two major cryonics providers in the US, so I figured it might be productive to start such a discussion myself by posing the question to the community: which provider would you choose, all things being equal: Alcor or the Cryonics Institute?
From my research, Alcor comes across as the flasher, higher-end option, while CI seems more like a Mom-and-Pop operation, having only two full-time employees. Alcor also costs substantially more, with its neurosuspension option alone running ~$80k, compared with CI's whole-body preservation cost of ~$30k. While Alcor has received far more publicity than CI, much of it has been negative. The Ted Williams fiasco is probably the most prominent example, although the accuser in that case seems anything but trustworthy. However, Alcor remains something of a shadowy organization that many within the cryonics community are suspicious of. Mike Darwin, a former Alcor president, has written at length on both organizations at http://www.chronopause.com, and on the whole, at least based on what I've read, Alcor comes across looking less competent, less trustworthy, and less open than CI.
One issue in particular is funding. Even though Alcor costs much more, it has many more expenses, and Darwin and others have questioned the long term financial stability of the organization. Ralph Merkle, an Alcor board member and elder statesman of cryonics who has made significant contributions to other fields like nanotechnology, a field he practically invented, and encryption, with Merkle's Puzzles, has essentially admitted(1) that Alcor hasn't managed its money very well:
"Some Alcor members have wondered why rich Alcor members have not donated more money to Alcor. The major reason is that rich Alcor members are rich because they know how to manage money, and they know that Alcor traditionally has managed money poorly. Why give any significant amount of money to an organization that has no fiscal discipline? It will just spend it, and put itself right back into the same financial hole it’s already in.
As a case in point, consider Alcor’s efforts over the year to create an “endowment fund” to stabilize its operating budget. These efforts have always ended with Alcor spending the money on various useful activities. These range from research projects to subsidizing our existing members — raising dues and minimums is a painful thing to do, and the Board is always reluctant to do this even when the financial data is clear. While each such project is individually worthy and has merit, collectively the result has been to thwart the effort to create a lasting endowment and leave Alcor in a financially weak position."
Such an acknowledgement, though appreciated, is frankly disturbing, considering that members depend utterly on these organizations remaining operational and solvent for decades, perhaps even centuries, after they are deanimated.
Meanwhile, CI carries on merrily, well under the radar, seemingly without any drama or intrigue. And Ben Best seems to have very good credentials in the cryonics community, and Eliezer, one of the most prominent public advocates of cryonics, is signed up with them. Yet the tiny size of the operation still fills me with unease concerning its prospects for long-term survivability.
So with all of that said, besides cost, what factors would lead or have led you to pick one organization over the other?
1: http://www.alcor.org/Library/html/CryopreservationFundingAndInflation.html